Ensysce Biosciences announced this week the publication of data showing that its carbon nanotube technology can be used to deliver siRNAs.
According to the company, the findings show that single-walled carbon nanotubes can protect siRNAs in circulation and deliver them into tumors in vivo. The paper was published in the journal Materials.
A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.
Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
